- Home
- WK vs AXSM Comparison
WK vs AXSM Comparison
Compare WK & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WK | AXSM |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | 925 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 12.0B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | WK | AXSM |
|---|---|---|
| Price | $48.64 | $228.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | $95.30 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 1.3M | 818.7K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.53 | 38.56 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $884,568,000.00 | N/A |
| Revenue This Year | $20.85 | $57.24 |
| Revenue Next Year | $15.43 | $55.88 |
| P/E Ratio | $151.29 | ★ N/A |
| Revenue Growth | ★ 19.75 | N/A |
| 52 Week Low | $43.34 | $96.09 |
| 52 Week High | $97.10 | $235.92 |
Technical Indicators
Market Signals| Indicator | WK | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 69.95 |
| Support Level | $43.34 | $148.87 |
| Resistance Level | $58.02 | $235.10 |
| Average True Range (ATR) | 2.84 | 8.58 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 35.99 | 82.76 |
Price Performance
Historical ComparisonAbout WK Workiva Inc.
Workiva Inc is an AI-powered platform for trust, transparency, and accountability. Accounting, finance, sustainability, risk, and audit teams rely on Workiva for their mission-critical work. It transforms how customers connect data, unify processes, and empower teams in a secure, AI-powered, audit-ready, collaborative platform. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.